Resa Schlossberg

Resa Schlossberg leads Skadden's intellectual property and technology transactions practice. She counsels clients across a broad range of industries on complex IP-related matters, with a particular emphasis on life sciences and technology-intensive representations. Her practice encompasses the structuring, drafting, and negotiation of joint ventures, strategic alliances, licenses, mergers and acquisitions, R&D funding, synthetic royalty and a wide variety of commercial agreements, including research and development, collaboration, co-marketing, co-promotion, manufacturing and supply, and consulting arrangements. She also regularly conducts IP diligence and evaluates technologies on behalf of clients in the pharmaceutical, chemical, biotechnology, cosmetic, medical device, and renewable energy sectors, among others.

Ms. Schlossberg's background in molecular biophysics and biochemistry, together with her research experience, enables her to grasp the scientific and technical dimensions of the matters she handles.

Ms. Schlossberg has been repeatedly recognized as one of the Top 250 Women in IP and a Transactions Star by Managing IP, ranked among LMG Life Sciences' leading practitioners for Licensing & Collaboration and Mergers & Acquisitions, and selected to Intellectual Asset Management's IAM Patent 1000, which describes her as a "master at executing a deep dive into target and competitor portfolios, formulating strategies, structuring deals and successfully negotiating them." She has likewise been named to Lawdragon's 500 Leading Lawyers in America, 500 Leading Global IP Lawyers, and 500 Leading Dealmakers in America.

Ms. Schlossberg earned her J.D. from Columbia Law School, where she was a Harlan Fiske Stone Scholar, and her B.S. in Molecular Biophysics and Biochemistry from Yale University.

Beyond her transactional practice, Ms. Schlossberg also has experience litigating patent infringement disputes in U.S. federal court, representing clients in false advertising and consumer deception matters, and counseling on a variety of strategic IP issues. She is a registered patent attorney with the U.S. Patent and Trademark Office.